Department of Gastroenterology, Jinhua Hospital of Zhejiang University School of Medicine, Wucheng, Jinhua, China.
Turk J Gastroenterol. 2024 Jun;35(6):481-487. doi: 10.5152/tjg.2024.23487.
BACKGROUND/AIMS: There is a lack of effective and safe methods for preventing esophageal stricture after large endoscopic submucosal dissection (ESD) in patients with superficial esophageal cancer. We aimed to compare the effectiveness of oral prednisolone alone versus a combination of oral prednisolone and nasogastric tube in preventing esophageal stricture following extensive ESD.
We retrospectively gathered clinical data from a single center on patients with early esophageal cancer who underwent ESD. Patients were categorized into 2 groups: the steroid group (receiving only oral prednisolone) and the steroid+nasogastric tube retention (NGT) group. We analyzed the incidence of esophageal stricture and identified risk factors for its development.
The study included 79 patients, with 30 in the steroid group and 49 in the steroid+NGT group. The incidence of stricture was significantly higher in the steroid group (9/30, 30.0%) compared to the steroid+NGT group (3/49, 6.1%) (P = .004). Notably, we observed a significant difference in the stricture rates between the 2 groups, particularly in patients with a complete circumferential defect (100% and 16.7%) (P = .015). Multivariate logistic regression analysis revealed that a full circumferential defect of the esophageal mucosa (OR 12.501; 95% CI 1.907, 81.047; P = .008), invasion depth beyond the lamina propria (OR 5.635; 95% CI 1.039, 30.559; P = .045), and the absence of NGT retention (OR 12.896; 95% CI 2.099, 79.219; P = .006) were independent risk factors predicting the development of a stricture.
The combination of steroids with NGT retention is more effective than using oral steroids alone in preventing esophageal stricture after extensive ESD.
背景/目的:对于浅层食管癌患者,内镜黏膜下剥离术(ESD)后预防食管狭窄的有效且安全的方法仍然缺乏。本研究旨在比较单独口服泼尼松龙与泼尼松龙联合鼻胃管对广泛 ESD 后食管狭窄的预防效果。
我们回顾性地收集了单中心早期食管癌患者接受 ESD 治疗的临床资料。患者分为 2 组:激素组(仅接受口服泼尼松龙)和激素+胃管保留(NGT)组。我们分析了食管狭窄的发生率,并确定了其发展的危险因素。
本研究共纳入 79 例患者,其中激素组 30 例,激素+NGT 组 49 例。激素组狭窄发生率(9/30,30.0%)显著高于激素+NGT 组(3/49,6.1%)(P =.004)。值得注意的是,我们观察到两组之间狭窄发生率存在显著差异,特别是在完全环周缺损的患者中(100%和 16.7%)(P =.015)。多变量 logistic 回归分析显示,食管黏膜全环周缺损(OR 12.501;95%CI 1.907,81.047;P =.008)、黏膜固有层以外的浸润深度(OR 5.635;95%CI 1.039,30.559;P =.045)和无 NGT 保留(OR 12.896;95%CI 2.099,79.219;P =.006)是预测狭窄发生的独立危险因素。
与单独使用口服泼尼松龙相比,泼尼松龙联合 NGT 保留对广泛 ESD 后预防食管狭窄更有效。